A Decade After Approval of the First CDK4/6 Inhibitor: A Look Back at Palbociclib's Journey from Discovery to Approval and What's Next in CDK Inhibition in Breast Cancer. - Finn RS; Rugo HS; Cortes J; Loibl S; Foley G; Gauthier E; Wang Y; Kim S; Anders L; Slamon DJ (Targeted oncology, 2025)